𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Myelodysplastic syndromes: A study of surface markers and in vitro growth patterns

✍ Scribed by Denis Guyotat; Lydia Campos; Xavier Thomas; Liliana Vila; Zhi-Hua Shi; Christiane Charrin; Odile Gentilhomme; Denis Fiere

Book ID
102698281
Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
538 KB
Volume
34
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Bone marrow in vitro growth and cytogene
Bone marrow in vitro growth and cytogenetic studies in patients with fab-classified primary myelodysplastic syndromes
✍ Birgitta Swolin; Stig RΓΆdjer; Jan Westin πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 537 KB

Thirty-eight consecutive patients with a FAB-classified primary myelodysplastic syndrome (MDS) were investigated for in vitro growth of colony-forming units for granulocyte-macrophage precursors (CFU-GM) and cytogenetic analysis of bone marrow cells. Abnormal CFU-GM growth was found in 30 patients (

Decitabine improves patient outcomes in
Decitabine improves patient outcomes in myelodysplastic syndromes : Results of a phase III randomized study
✍ Hagop Kantarjian; Jean-Pierre J. Issa; Craig S. Rosenfeld; John M. Bennett; Mahe πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 204 KB

## Abstract ## BACKGROUND Aberrant DNA methylation, which results in leukemogenesis, is frequent in patients with myelodysplastic syndromes (MDS) and is a potential target for pharmacologic therapy. Decitabine indirectly depletes methylcytosine and causes hypomethylation of target gene promoters.